Considering our previous findings [17], the present study investigates the beneficial impact of metformin treatment in reducing ROS overproduction and mitigating the associated oxidative stress condition in LCLs derived from AGS patients carrying mutations in the RNASEH2B and RNASEH2A genes, as well as from healthy controls. This evidence concerns the gene RNASEH2A and Aicardi-Goutieres syndrome.